StockCall.com Provides Stock Research on Elan, Community Health Systems, Santarus, and Cubist Pharma
New York City, New York -- (April 24, 2013)
Markets remained positive as Santarus Inc. (NASDAQ: SNTS) hit its new 52-week high price point of $19.20. All the major indices remained bullish as S&P 500 Index closed 1.04 percent higher at 1,578.78. The healthcare sector also performed well as other major stocks including Elan Corporation (NYSE: ELN), Community Health Systems (NYSE: CYH), and Cubist Pharmaceuticals Inc (NASDAQ: CBST) posted good gains for the session. StockCall has posted free technical research on ELN, CYH, SNTS, and CBST which can be downloaded upon sign up at
Elan Corporation closed Tuesday’s trading session at $11.99, down 0.25 percent from its previous close. The stock shows a neutral trend but currently it is in the overbought territory with Relative Strength Index of 62.16. It is likely to face a minor pullback in the coming trading sessions and may find support at $11.93. Upon breaching this level, it may go down to $11.50 level. Elan traded 4.81 million shares during yesterday’s session, and the stock oscillated in the range of $11.96 and $12.10. It has declined 12.86 percent in the past 52 weeks while its YTD gain stands at 19.42 percent. Sign up and read the complimentary report on ELN at
Community Health Systems made an upward movement with 1.58 percent gain in its latest trading session. The company’s stock ended at $42.46 and its highest price point for the session stood at $42.85. In the past 12 months, the stock has gained 81.69 percent while its YTD gain stands at 41.82 percent. The company trades at beta of 1.64, which implies high volatility. It traded 1.32 million shares during Tuesday’s session, in comparison to its regular daily volume of 1.27 million shares. Community Health Systems commands market capitalization of $3.99 billion, and it has oscillated between $20.71 and $48.59 in the past 52 weeks. The free report on CYH can be downloaded by signing up now at
Santarus Inc. extended its 52 weeks gain to 222.17 percent by closing Tuesday’s trading session 0.63 percent higher. The stock closed at $19.04, with trading volume of 821,857 shares. The stock traded between $18.70 and $19.20 during yesterday’s trading session. It is up 77.12 percent on a YTD basis. Santarus is currently in a bullish mode and is expected to go up to $19.75 in the coming sessions. Its next resistance level is at $20.05. On the downside, it is expected to face its first support level at $18.23. The company’s stock traded in the range of $4.82 and $19.20 in the past 52 weeks. Free report on SNTS can be accessed by registering at
Cubist Pharmaceuticals Inc is currently trading above its 20-day and 50-day moving average price of $46.83 and $46.85 respectively, and it is in a bullish mode. It also ended its latest trading session 0.11 percent higher at $46.96, further confirming the trend. Cubist Pharma exchanged 740,074 shares during Tuesday’s session. The stock has outperformed the broader markets and has gained 12.88 percent so far this year. However, it is likely to go up to $48.06 in the coming trading sessions. Its second resistance level is at $48.79. Cubist commands market capitalization of $3.06 billion. Its stock shows low volatility with beta of 0.55.Register withStockCall and download the research on CBST for free at
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at
William T. Knight
Contact Number: (646) 396-9857 (9:00 am EST – 01:30 pm EST)
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here